Evidence Based Probiotic Therapy of Proton Pump Inhibitor Induced Dysbiosis (NCT05836155) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evidence Based Probiotic Therapy of Proton Pump Inhibitor Induced Dysbiosis
Austria53 participantsStarted 2023-07-10
Plain-language summary
In this study the investigators aim to test whether an evidence based probiotic is able to revert proton pump inhibitor induced dysbiosis of the gut microbiome.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \>18;
* Signed Informed Consent;
* PPI intake for at least 3 months;
* Willing to accept use of all encoded data, including publication, and the confidential use and storage of all data for at least 15 years; Exclusion criteria
* Diagnosed with a gastrointestinal infection within 4 weeks prior to screening; Severe gastrointestinal disorders (e.g. inflammatory bowel diseases)
* Received any of the following products/medication prior to screening: systemic antibiotics, prokinetics, prebiotic supplements, probiotic supplements within 4 weeks prior to screening;
* Concomitant diseases or other circumstances that suggest that the patients are not eligible for participation in the study